{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T21:47:08Z","timestamp":1788904028643,"version":"build-2803163510"},"reference-count":50,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2016,9,1]],"date-time":"2016-09-01T00:00:00Z","timestamp":1472688000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,9,1]],"date-time":"2017-09-01T00:00:00Z","timestamp":1504224000000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["jidonline.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Investigative Dermatology"],"published-print":{"date-parts":[[2016,9]]},"DOI":"10.1016\/j.jid.2016.02.816","type":"journal-article","created":{"date-parts":[[2016,5,25]],"date-time":"2016-05-25T13:57:33Z","timestamp":1464184653000},"page":"1801-1810","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":49,"title":["Myeloid-Derived Suppressor Cells in Psoriasis Are an Expanded Population Exhibiting Diverse T-Cell\u2013Suppressor Mechanisms"],"prefix":"10.1016","volume":"136","author":[{"given":"Lauren Y.","family":"Cao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin-Sung","family":"Chung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takahiro","family":"Teshima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lawrence","family":"Feigenbaum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"Jr.","given":"Ponciano D.","family":"Cruz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heidi T.","family":"Jacobe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin F.","family":"Chong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kiyoshi","family":"Ariizumi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jid.2016.02.816_bib1","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1172\/JCI5857","article-title":"CTLA4Ig-mediated blockade of T-cell costimulation in patients with psoriasis vulgaris","volume":"103","author":"Abrams","year":"1999","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.jid.2016.02.816_bib2","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1159\/000093849","article-title":"Identification of lesional CD4+ CD25+ Foxp3+ regulatory T cells in Psoriasis","volume":"213","author":"Bovenschen","year":"2006","journal-title":"Dermatology"},{"key":"10.1016\/j.jid.2016.02.816_bib3","doi-asserted-by":"crossref","first-page":"976793","DOI":"10.1155\/2011\/976793","article-title":"T-cell costimulatory molecules in acute-graft-versus host disease: therapeutic implications","volume":"2011","author":"Briones","year":"2011","journal-title":"Bone Marrow Res"},{"key":"10.1016\/j.jid.2016.02.816_bib4","doi-asserted-by":"crossref","first-page":"2577","DOI":"10.1084\/jem.20060244","article-title":"L-23 stimulates epidermal hyperplasia via TNF and IL-20R2-dependent mechanisms with implications for psoriasis pathogenesis","volume":"203","author":"Chan","year":"2006","journal-title":"J\u00a0Exp Med"},{"key":"10.1016\/j.jid.2016.02.816_bib5","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1002\/biof.62","article-title":"CD40\/CD40L signaling and its implication in health and disease","volume":"35","author":"Chatzigeorgiou","year":"2009","journal-title":"Biofactors"},{"key":"10.1016\/j.jid.2016.02.816_bib6","doi-asserted-by":"crossref","first-page":"2235","DOI":"10.1084\/jem.20080132","article-title":"Inhibition of dendritic cell differentiation and accumulation of myeloid-derived suppressor cells in cancer is regulated by S100A9 protein","volume":"205","author":"Cheng","year":"2008","journal-title":"J\u00a0Exp Med"},{"key":"10.1016\/j.jid.2016.02.816_bib7","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1002\/eji.200838990","article-title":"The DC-HIL\/syndecan-4 pathway inhibits human allogeneic T-cell responses","volume":"39","author":"Chung","year":"2009","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.jid.2016.02.816_bib8","doi-asserted-by":"crossref","first-page":"5778","DOI":"10.4049\/jimmunol.179.9.5778","article-title":"Syndecan-4 mediates the coinhibitory function of DC-HIL on T cell activation","volume":"179","author":"Chung","year":"2007","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.jid.2016.02.816_bib9","doi-asserted-by":"crossref","first-page":"4320","DOI":"10.1182\/blood-2006-11-053769","article-title":"DC-HIL is a negative regulator of T lymphocyte activation","volume":"109","author":"Chung","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.jid.2016.02.816_bib10","doi-asserted-by":"crossref","first-page":"2576","DOI":"10.4049\/jimmunol.1301857","article-title":"The DC-HIL\/syndecan-4 pathway regulates autoimmune responses through myeloid-derived suppressor cells","volume":"192","author":"Chung","year":"2014","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.jid.2016.02.816_bib11","doi-asserted-by":"crossref","first-page":"2784","DOI":"10.1038\/jid.2014.254","article-title":"DC-HIL-expressing myelomonocytic cells are critical promoters of melanoma growth","volume":"134","author":"Chung","year":"2014","journal-title":"J\u00a0Invest Dermatol"},{"key":"10.1016\/j.jid.2016.02.816_bib12","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1111\/imm.12027","article-title":"The DC-HIL ligand syndecan-4 is a negative regulator of T-cell allo-reactivity responsible for graft-versus-host disease","volume":"138","author":"Chung","year":"2013","journal-title":"Immunology"},{"key":"10.1016\/j.jid.2016.02.816_bib13","doi-asserted-by":"crossref","first-page":"4431","DOI":"10.4049\/jimmunol.176.7.4431","article-title":"The vast majority of CLA+ T cells are resident in normal skin","volume":"176","author":"Clark","year":"2006","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.jid.2016.02.816_bib14","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1016\/j.intimp.2011.01.026","article-title":"MDSC in autoimmunity","volume":"11","author":"Cripps","year":"2011","journal-title":"Int Immunopharmacol"},{"key":"10.1016\/j.jid.2016.02.816_bib15","doi-asserted-by":"crossref","first-page":"281","DOI":"10.2119\/molmed.2010.00178","article-title":"A\u00a0paradoxical role for myeloid-derived suppressor cells in sepsis and trauma","volume":"17","author":"Cuenca","year":"2011","journal-title":"Mol Med"},{"key":"10.1016\/j.jid.2016.02.816_bib16","doi-asserted-by":"crossref","first-page":"4185","DOI":"10.1073\/pnas.0409783102","article-title":"Nitroaspirin corrects immune dysfunction in tumor-bearing hosts and promotes tumor eradication by cancer vaccination","volume":"102","author":"De Santo","year":"2005","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.jid.2016.02.816_bib17","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1038\/jid.2009.59","article-title":"The IL-23\/Th17 axis in the immunopathogenesis of psoriasis","volume":"129","author":"Di Cesare","year":"2009","journal-title":"J\u00a0Invest Dermatol"},{"key":"10.1016\/j.jid.2016.02.816_bib18","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1164\/rccm.201302-0249OC","article-title":"Increased frequency of myeloid-derived suppressor cells during Active tuberculosis and after recent mycobacterium tuberculosis infection suppresses T-cell function","volume":"188","author":"du Plessis","year":"2013","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jid.2016.02.816_bib19","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1038\/ni0702-611","article-title":"CTLA-4: new insights into its biological function and use in tumor immunotherapy","volume":"3","author":"Egen","year":"2002","journal-title":"Nat Immunol"},{"key":"10.1016\/j.jid.2016.02.816_bib20","doi-asserted-by":"crossref","first-page":"4794","DOI":"10.1074\/jbc.274.8.4794","article-title":"Role of interferon regulatory factor-1 and mitogen-activated protein kinase pathways in the induction of nitric oxide synthase-2 in retinal pigmented epithelial cells","volume":"274","author":"Faure","year":"1999","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.jid.2016.02.816_bib21","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1006\/jaut.1999.0343","article-title":"CD69, HLA-DR and the IL-2R identify persistently activated T cells in psoriasis vulgaris lesional skin: blood and skin comparisons by flow cytometry","volume":"14","author":"Ferenczi","year":"2000","journal-title":"J\u00a0Autoimmun"},{"key":"10.1016\/j.jid.2016.02.816_bib22","doi-asserted-by":"crossref","first-page":"2546","DOI":"10.1200\/JCO.2006.08.5829","article-title":"Identification of a new subset of myeloid suppressor cells in peripheral blood of melanoma patients with modulation by a granulocyte-macrophage colony-stimulation factor-based antitumor vaccine","volume":"25","author":"Filipazzi","year":"2007","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.jid.2016.02.816_bib23","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1111\/j.1600-065X.2010.00923.x","article-title":"The PD-1 pathway in tolerance and autoimmunity","volume":"236","author":"Francisco","year":"2010","journal-title":"Immunol Rev"},{"key":"10.1016\/j.jid.2016.02.816_bib24","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1159\/000250839","article-title":"Severe psoriasis\u2014oral therapy with a new retinoid","volume":"157","author":"Fredriksson","year":"1978","journal-title":"Dermatologica"},{"key":"10.1016\/j.jid.2016.02.816_bib25","doi-asserted-by":"crossref","first-page":"2587","DOI":"10.1172\/JCI29906","article-title":"Myeloid suppressor cells regulate the adaptive immune response to cancer","volume":"116","author":"Frey","year":"2006","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.jid.2016.02.816_bib26","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1038\/40166","article-title":"Cutaneous lymphocyte antigen is a specialized form of PSGL-1 expressed on skin-homing T cells","volume":"389","author":"Fuhlbrigge","year":"1997","journal-title":"Nature"},{"key":"10.1016\/j.jid.2016.02.816_bib27","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.4049\/jimmunol.1203535","article-title":"Myeloid-derived suppressor cells play crucial roles in the regulation of mouse collagen-induced arthritis","volume":"191","author":"Fujii","year":"2013","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.jid.2016.02.816_bib28","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1038\/nri2506","article-title":"Myeloid-derived suppressor cells as regulators of the immune system","volume":"9","author":"Gabrilovich","year":"2009","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.jid.2016.02.816_bib29","doi-asserted-by":"crossref","first-page":"2281","DOI":"10.4049\/jimmunol.0902574","article-title":"IL-17 promotes tumor development through the induction of tumor promoting microenvironments at tumor sites and myeloid-derived suppressor cells","volume":"184","author":"He","year":"2010","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.jid.2016.02.816_bib30","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/S0065-2776(10)05003-0","article-title":"OX40-OX40 ligand interaction in T-cell-mediated immunity and immunopathology","volume":"105","author":"Ishii","year":"2010","journal-title":"Adv Immunol"},{"key":"10.1016\/j.jid.2016.02.816_bib31","doi-asserted-by":"crossref","first-page":"367","DOI":"10.2340\/00015555-1285","article-title":"Impaired expression of Tim-3 on Th17 and Th1 cells in psoriasis","volume":"92","author":"Kanai","year":"2012","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/j.jid.2016.02.816_bib32","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1146\/annurev-immunol-032713-120225","article-title":"Immunology of psoriasis","volume":"32","author":"Lowes","year":"2014","journal-title":"Ann Rev Immunol"},{"key":"10.1016\/j.jid.2016.02.816_bib33","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1111\/j.1744-313X.2007.00736.x","article-title":"Distribution of the CTLA-4 single nucleotide polymorphisms CT60G>A and\u00a0+49A>G in psoriasis vulgaris patients and control individuals from a Polish Caucasian population","volume":"35","author":"Luszczek","year":"2008","journal-title":"Int J Immunogenet"},{"key":"10.1016\/j.jid.2016.02.816_bib34","first-page":"597","article-title":"IL-22 is required for Th17 cell-mediated pathology in a mouse model of psoriasis-like skin inflammation","volume":"118","author":"Ma","year":"2008","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.jid.2016.02.816_bib35","doi-asserted-by":"crossref","first-page":"5071","DOI":"10.4049\/jimmunol.179.8.5071","article-title":"The importance of myeloid-derived suppressor cells in the regulation of autoimmune effector cells by a chronic contact eczema","volume":"179","author":"Marhaba","year":"2007","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.jid.2016.02.816_bib36","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1155\/2013\/856056","article-title":"Serum levels of selected Th17 and Th22 cytokines in psoriatic patients","volume":"35","author":"Michalak-Stoma","year":"2013","journal-title":"Dis Markers"},{"key":"10.1016\/j.jid.2016.02.816_bib50","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.cytogfr.2003.10.003","article-title":"Inducible nitric oxide synthase activation by interleukin-17","volume":"15","author":"Miljkovic","year":"2014","journal-title":"Cytokine Growth Factor Rev"},{"key":"10.1016\/j.jid.2016.02.816_bib37","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.jdermsci.2010.10.012","article-title":"Association between T-lymphocyte regulatory gene CTLA4 single nucleotide polymorphism at position 49 in exon 1 and HLA-DRB1*08 in Japanese patients with psoriasis vulgaris","volume":"62","author":"Muto","year":"2011","journal-title":"J\u00a0Dermatol Sci"},{"key":"10.1016\/j.jid.2016.02.816_bib38","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.1111\/jdv.13027","article-title":"Increased circulating follicular helper T cells and activated B cells correlate with disease severity in patients with psoriasis","volume":"29","author":"Niu","year":"2015","journal-title":"J\u00a0Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.jid.2016.02.816_bib39","doi-asserted-by":"crossref","first-page":"1969","DOI":"10.1038\/jid.2008.38","article-title":"FR255734, a humanized, Fc-Silent, Anti-CD28 antibody, improves psoriasis in the SCID mouse-psoriasis xenograft model","volume":"128","author":"Raychaudhuri","year":"2008","journal-title":"J\u00a0Invest Dermatol"},{"key":"10.1016\/j.jid.2016.02.816_bib40","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/j.det.2013.04.009","article-title":"Psoriasis as autoinflammatory disease","volume":"31","author":"Rivas Bejarano","year":"2013","journal-title":"Dermatol Clin"},{"key":"10.1016\/j.jid.2016.02.816_bib41","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.semcancer.2005.07.005","article-title":"Myeloid suppressor cells in cancer: recruitment, phenotype, properties, and mechanisms of immune suppression","volume":"16","author":"Serafini","year":"2006","journal-title":"Semin Cancer Biol"},{"key":"10.1016\/j.jid.2016.02.816_bib42","doi-asserted-by":"crossref","first-page":"5439","DOI":"10.1158\/0008-5472.CAN-07-6621","article-title":"Myeloid-derived suppressor cells promote cross-tolerance in B-cell lymphoma by expanding regulatory T\u00a0cells","volume":"68","author":"Serafini","year":"2008","journal-title":"Cancer Res"},{"key":"10.1016\/j.jid.2016.02.816_bib43","first-page":"21","article-title":"A\u00a0possible pathogenic role of CD4+CD25+ T-regulatory cells in psoriasis","volume":"14","author":"Shehata","year":"2007","journal-title":"Egypt J Immunol"},{"key":"10.1016\/j.jid.2016.02.816_bib44","doi-asserted-by":"crossref","first-page":"2871","DOI":"10.1002\/eji.201141696","article-title":"Delayed type hypersensitivity-induced myeloid-derived suppressor cells regulate autoreactive T cells","volume":"41","author":"Singh","year":"2011","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.jid.2016.02.816_bib45","first-page":"392","article-title":"Interleukin-17A promotes arginase-1 production and 2,4-dinitrochlorobenzene-induced acute hyperinflammation in human papillomavirus E7 oncoprotein-expressing skin","volume":"7","author":"Tran le","year":"2015","journal-title":"J\u00a0Innate Immun"},{"key":"10.1016\/j.jid.2016.02.816_bib46","doi-asserted-by":"crossref","first-page":"2839","DOI":"10.1038\/jid.2014.248","article-title":"DC-HIL+ CD14+ HLA-DRno\/low cells are a potential blood marker and therapeutic target for melanoma","volume":"134","author":"Turrentine","year":"2014","journal-title":"J\u00a0Invest Dermatol"},{"key":"10.1016\/j.jid.2016.02.816_bib47","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1016\/j.micinf.2004.03.007","article-title":"Co-signaling molecules of the B7-CD28 family in positive and negative regulation of T lymphocyte responses","volume":"6","author":"Wang","year":"2004","journal-title":"Microbes Infect"},{"key":"10.1016\/j.jid.2016.02.816_bib48","doi-asserted-by":"crossref","first-page":"2969","DOI":"10.1002\/eji.201040895","article-title":"The biology of myeloid-derived suppressor cells: the\u00a0blessing and the curse of morphological and functional heterogeneity","volume":"40","author":"Youn","year":"2010","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.jid.2016.02.816_bib49","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.clim.2009.11.008","article-title":"Increased Th17 cells are accompanied by FoxP3(+) Treg cell accumulation and correlated with psoriasis disease severity","volume":"135","author":"Zhang","year":"2010","journal-title":"Clin Immunol"}],"container-title":["Journal of Investigative Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022202X16312581?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022202X16312581?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,8,18]],"date-time":"2023-08-18T12:35:47Z","timestamp":1692362147000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022202X16312581"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,9]]},"references-count":50,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2016,9]]}},"alternative-id":["S0022202X16312581"],"URL":"https:\/\/doi.org\/10.1016\/j.jid.2016.02.816","relation":{},"ISSN":["0022-202X"],"issn-type":[{"value":"0022-202X","type":"print"}],"subject":[],"published":{"date-parts":[[2016,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Myeloid-Derived Suppressor Cells in Psoriasis Are an Expanded Population Exhibiting Diverse T-Cell\u2013Suppressor Mechanisms","name":"articletitle","label":"Article Title"},{"value":"Journal of Investigative Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jid.2016.02.816","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.jid.2016.04.029","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 The Authors. Published by Elsevier, Inc. on behalf of the Society for Investigative Dermatology.","name":"copyright","label":"Copyright"}]}}